The total return over the past 12 months is -33.18% vs. +16.94% for the S&P 500. So far it's up -31.48% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (33.18%) | +45.43% | (31.08%) | (30.50%) | N/A | N/A |
| Total Return CAGR | (33.18%) | +45.43% | (31.08%) | (30.49%) | N/A | N/A |
| Revenue CAGR | (100.00%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Benitec Biopharma Inc. (BNTC)
| Year | Start price | End price | BNTC Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $13.47 | $9.23 | (31.48%) | +14.51% | (45.99%) |
| 2025 | $12.63 | $13.47 | +6.65% | +17.72% | (11.07%) |
| 2024 | $3.23 | $12.63 | +291.02% | +24.89% | +266.13% |
| 2023 | $2.89 | $3.23 | +11.76% | +26.19% | (14.43%) |
| 2022 | $44.54 | $2.89 | (93.51%) | (18.17%) | (75.34%) |
| 2021 | $51.00 | $44.54 | (12.67%) | +28.74% | (41.41%) |
| 2020 | $130.05 | $51.00 | (60.78%) | +18.37% | (79.15%) |
| 2019 | $382.50 | $130.05 | (66.00%) | +31.22% | (97.22%) |
| 2018 | $754.80 | $382.50 | (49.26%) | (4.56%) | (44.70%) |
| 2017 | $390.15 | $754.80 | +93.46% | +21.70% | +71.76% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
